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Although the term often implies a relationship with 
food ingestion and majority of  patients have symptoms 
worsened by food[2] this is no longer essential. Dyspeptic 
symptoms occur commonly in the general community[3] 
and constitute one of  the most frequent reasons for 
referral to gastroenterologists[4]. Surveys suggest as many 
as 15%-20% of  the population in Western countries 
experience dyspepsia over the course of  one year[5]. 
During investigation of  dyspepsia, three major structural 
causes are readily identifiable: peptic ulcer disease 
(10%), gastroesophageal refIux (20%)(with or without 
oesophagitis), and malignancy (2%)[6]. It is apparent that 
most (50%-70%) patients with chronic dyspepsia do 
not have a significant focal or structural lesion found at 
endoscopy. When symptoms are chronic or recurrent, 
but without an identifi able structural cause using standard 
diagnostic tests (usually endoscopy), the condition is 
usually labelled functional (or non-ulcer) dyspepsia[7]. 
Hence functional dyspepsia is a diagnosis of  exclusion that 
implies that symptoms have been investigated without the 
demonstration of  an organic or anatomical cause. 
INITIAL APPROACHES TO CLASSIFICATION 
INTO SUBTYPES
To standardise research studies amongst this heterogenous 
population of  patients, a definition of  functional 
dyspepsia was developed by consensus amongst a group 
of  international experts. In addition to describing the 
nature of  reported symptoms a temporal component 
of  persistent or recurrent for 4 wk in a 3 mo period was 
included[1]. This was subsequently modified to include 
more than 12 wk in one year[8]. As many patients with a 
final diagnosis of  functional dyspepsia presented with 
symptoms suggestive of  specific diseases initial efforts 
to subcategorise the syndrome, proposed subdividing 
dyspepsia into symptom-based subgroups namely refl ux-
like, ulcer-like, dysmotility like and non-specified[1].
The underlying expectation was that such subgroups 
would share common pathophysiology and might also 
respond to specific therapy. However, as is typical of  a 
chronic condition, the manifestations of  dyspepsia can 
be complex. Patients with upper abdominal discomfort 
frequently complain of  a multiple of  related symptoms. 
(Table 1)[9]. Indeed population-based studies indicate that 
patients presenting with uninvestigated dyspepsia, have 
at least three dyspepsia symptoms; more than 80% have 
at least six and approximately half  have eight or more[10]. 
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Abstract
Functional dyspepsia is a common clinical condition 
characterised by chronic or recurrent upper abdominal 
pain or discomfort commonly associated with a variety 
of associated gastrointestinal symptoms and a normal 
endoscopy. To standardise research-based approaches, 
an initial categorisation of into sub groups was agreed 
to, based on clusters of symptoms. However the early 
expectation that these subgroups would be associated 
with distinct pathophysiologies amenable to specific 
therapy has not been realised. A classifi cation based on 
the most troublesome symptom has been suggested 
but the utility of this is also unclear. More recent data 
suggest that some of the pathophysiologic dysfunctions 
may be associated with specific symptoms and so 
provide a better tool for grouping patients. But this 
approach remains incomplete as current insights into 
the pathogenesis are still too limited for this to be 
satisfactory. In conclusion, no classifi cation provides for 
an adequate treatment-based approach to the syndrome 
of functional dyspepsia. As a consequence treatment 
remains largely empiric.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
Dyspepsia is broadly defined by predominantly midline 
pain or discomfort located in the upper abdomen[1]. 
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Furthermore, symptoms often vary over time. The initial 
classifi cations were expanded to include cluster analysis of  
these associated symptoms.
With further intensive investigation, it has become 
apparent that dividing patients with uninvestigated 
dyspepsia empirically according to clusters of  symptoms 
has not assisted in identifying specific gastrointestinal 
mechanisms for different symptom types[11]. This may 
well refl ect the extensive overlap of  symptoms within the 
empirically derived groupings[12] the frequent association 
with ir ritable bowel syndrome[13] and the temporal 
variation in symptoms[9, 12, 13]. It also became apparent that 
the symptom sub classification was a poor predictor of  
underlying structural abnormality.[14]
SUB-TYPES IN FUNCTIONAL DYSPEPSIA 
POST ROME II (TABLE 2)
Concerns about the lack of  progress in understanding 
the syndrome and the overlap between various symptom 
clusters resulted in a refi nement of  these in a subsequrnt 
consensus agreement[8]. In particular the inclusion 
of  patients with predominant symptoms of  GORD 
was considered unwarranted as this entity should be 
distinguished in its own right. Thus the ROME II 
assessment of  Functional Gastrointestinal Disorders 
recognised three subtypes of  functional dyspepsia[8]. (1) 
Ulcer-like: Characterised by predominantly epigastric pain 
or discomfort which may worsen with hunger and improve 
with food or antacids. As with ulcer disease, symptoms 
may remit and relapse spontaneously. (2) Dysmotility-like: 
Contained clinical features suggestive of  disturbed upper 
gastrointestinal motility. Thus upper abdominal discomfort 
aggravated by food commonly associated with nausea, 
vomiting, bloating and upper satiety together. Anorexia 
also occurred in part because of  the consequences of  
food ingestion was also a feature and often associated 
with signifi cant weight loss. (3) Unspecifi ed: Patients with 
symptoms which did not fi t either of  the categories above.
As noted previously, patients with functional dyspepsia 
often do not fi t neatly into symptom cluster classifi cations, 
in part because of  the wide overlap of  symptoms[13]. 
The attempts to subgroup patients using the Rome II 
modifi cation has also not been particularly helpful in either 
clinical practice or research studies[11]. In addition the 
substantial overlap between dyspeptic groups, those with 
GORD and other functional gastrointestinal disorders 
has limited the utility of  this approach (Figure 1)[15] 
although it has been suggested that functional dyspepsia 
can usually be separated from symptoms related to the 
lower gut (ie Irritable Bowel Syndrome) by the presence of  
bowel disturbance despite the fact that many patients had 
both dyspepsia and IBS[16]. In the light of  the extensive 
symptom overlap and poor discriminatory value in 
individual patients, the value of  the cluster-based symptom 
classification has been questioned and possibly replaced 
by a subcategorisation based on the most troublesome 
symptom. The value of  this approach remains unproven[17]. 
Notwithstanding these restrictions, some recent data 
suggest that symptom clusters based around specific 
pathophysiologic disturbances may provide insights into 
the mechanisms of  the functional dyspepsia[2]. These 
appear to have predictive value and could possibly direct 
approaches to the development of  novel strategies.
Table 1 Defi nitions of dyspeptic symptoms
Symptom                    Description
Pain centred in the 
upper abdomen
A subjective unpleasant, patients may feel that 
tissue damage is occurring.  Other symptoms 
may be extremely bothersome A subjective 
unpleasant without being interpreted as pain.
Discomfort centred in 
the upper abdomen
A subjective unpleasant sensation that is not 
interpreted as pain, which may include any of 
the symptoms below.
Early satiety A feeling the stomach is overfilled soon after 
starting to eat, out of proportion to the size of 
the meal.
Fullness An unpleasant sensation of the persistence of 
food in the stomach (may or may not occur post 
prandially).
Bloating in the 
upper abdomen
A tightness in the upper abdomen, this 
should be distinguished from true abdominal 
distension.
Nausea A feeling of the need to vomit.
Retching Heaving as if to vomit but no gastric contents 
are forced up.
Table 2 Categorisation of Adult Functional Gastroenterological 
disorders as per Rome II[1]
A: Oesophageal disorders
     Globus
     Rumination syndrome
     Functional chest pain of presumed oesophageal origin
     Functional heartburn
     Functional dysphagia
     Unexplained functional oesophageal disorder
B:  Gastroduodenal disorders
     Functional dyspepsia
     Ulcer-like dyspepsia
     Dysmotility-like dyspepsia
     Unspecifi ed (non-specifi c dyspepsia)
     Aerophagia
     Functional vomiting
C: Bowel Disorders
     Irritable bowel syndrome
     Functional abdominal bloating
     Functional constipation
     Functional diarrhoea
     Unspecifi ed functional disorder
D: Functional abdominal pain
     Functional abdominal pain syndrome
     Unspecifi ed abdominal pain syndrome
E: Biliary Disorders
     Gall bladder dysfunction
     Sphincter of Oddi dysfunction
F:  Anorectal disorders
     Functional faecal incontinence
     Functional ano-rectal pain
     Levator ani syndrome
     Proctalgia Fugax
     Pelvic fl oor dyssynergia
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GORD and functional dyspepsia
It has become obvious that it is important to discriminate 
between symptoms related to GORD and functional 
dyspepsia. A sensation of  retrosternal or epigastric burning 
that characteristically radiates towards the throat, is 
precipitated by meals or the supine posture and is relieved 
at least temporarily by antacids, is strongly suggestive of  
GORD[15]. Frequent heartburn increases the likelihood 
of  GORD as the cause of  symptoms[6] although pyrhosis 
may be much less obvious in the older patient[18]. It is likely 
that the majority of  dyspeptic patients with predominantly 
refl ux symptoms have GORD, although only 50% of  these 
patients have oesophagitis at endoscopy. As noted above, 
the revised criteria in ROME II did not include reflux-
like dyspepsia as a sub-grouping of  functional dyspepsia, 
and patients with heartburn as their major symptom are 
now generally excluded from dyspepsia studies. However 
it needs to be recognized that many patients with GORD 
have multiple symptoms[10] and a substantial number of  
patients with GORD also have functional dyspepsia which 
may be unmasked by successful treatment of  GORD with 
PPI. A number of  patients with functional dyspepsia may 
have heartburn as an extra symptom and the prevalence of  
GORD in patients with epigastric pain alone is unknown. 
It is also unclear whether this could represent undiagnosed 
or non-erosive refl ux disease.
Pathophysiologically based sub-groups
The pathophysiology of  functional dyspepsia is unclear 
and a large number of  mechanisms proposed as causa-
tive[19]. These include delayed gastric emptying[20,21], visceral 
hypersensitivity[22], impaired gastric accommodation to 
meals[23], abnormal motility[24], infection with Helicobacter 
pylori (H pylori)[25] and CNS dysfunction. In addition, 
childhood abuse[26] and prior gastrointestinal infection[27] 
have been described as precursors to later dyspepsia. 
However, an association between the majority of  these 
mechanisms and specifi c symptoms is lacking.
CLASSIFICATION ACCORDING TO SPECIFIC 
PATHOPHYSIOLOGIES ASSOCIATED WITH 
FUNCTIONAL DYSPEPSIA
Gastric motor and sensory dysfunction
Although it has long been recognized that gastric emptying 
is delayed in approximately 1/3 of  patients with functional 
dyspepsia[20], this does not reliably predict individual 
patient symptoms, with the exception that there is some 
association with fullness and bloating[28, 29]. Gastric antral 
hypomotility measured by manometry is well described[24], 
but may well refl ect the limitations of  pressure recordings 
with non-lumen occlusive contractions. More promising 
are recent descriptions of  the proximal gastric function, 
which may permit better discrimination of  some sym-
ptoms related to meal ingestion[2]. Thus intolerance to 
gastric distension suggesting impaired visceral sensitivity 
has been associated with epigastric pain, and belching[22]. 
Similarly, impaired proximal gastric accommodation has 
been associated with pain, early satiety and weight loss 
particularly in young women[23]. Of  particular interest 
to clinicians, are reports that these abnormalities can be 
evaluated with a high calorie drink test[30]. This technique 
potentially allows an offi ce-based approach to address at 
least some symptoms in these patients, without resorting 
to invasive gastric barostat techniques, or expensive 
technology with limited availability[31-33]. 
Helicobacter pylori Infection
Depending on the population under study, between 
30%-65% of  patients diagnosed with functional dyspepsia 
have H pylori-induced gastritis[25,34]. However, a consistent 
causal link between H pylori infection and specific sym-
ptom profi les has not reliably been established[35]. H pylori 
positive individuals are as likely to have symptoms of  
bloating and early satiety as symptoms suggestive of  peptic 
ulcer[17]. Suggestions that H pylori infection has a signifi cant 
impact on gastric motility have also not been confi rmed[36]. 
It is feasible that some of  these patients could have 
undiagnosed peptic ulcer disease. At present, the aetiology 
of  symptoms in H pylori patients without peptic ulceration 
is unclear[37]. 
Intestinal hypersensitivity
Dyspeptic symptoms are frequently worsened by food 
especially those rich in fat. A heightened sensitivity to 
both lipids[38] and acid[39] have been reported to be possible 
mechanisms underlying symptoms. High fat meals slow 
gastric emptying and hence may accentuate bloating and 
fullness. A similar effect may be seen with high fi bre meals. 
These studies involved small numbers of  patients and their 
general applicability at this stage remains uncertain. 
CLASS IF ICAT ION ACCORDING TO 
POSSIBLE PATHOGENESIS
The pathogenesis of  functional dyspepsia is unknown and 
probably multi-factorial. Only a minority of  patients report 
previous gastrointestinal infection[27] or an acute onset 
compatible with a post-infective aetiology. Psychological 
factors especially stress[40] and previous abuse[26] have 
been suggested to be important but direct evidence for a 
causative role is yet to be established. A recent description 
of  an association between dyspeptic symptoms and a 
functional polymorphism of  a G-protein subunit[41] has 
demonstrated that patients who are homozygous for the 
GNB3 825C subunit have a higher incidence of  abdominal 
symptoms. The full implications of  this is currently under 
Ulcer-like Dysmotility-like
GORD Non-specifi c
Figure 1 Schema of overlap of dyspepsia subtypes (according to Rome II) and 
gastro-oesophageal refl ux disease[15].
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investigation. In the light of  these uncertainties, further 
data are required before a meaningful classifi cation based 
on potential pathogenesis can be undertaken.
THERAPEUTIC IMPLICATIONS
Given the limited understanding of  the pathophysiological 
basis for symptoms in functional dyspepsia, there are 
limited options for rational treatment. It appears however 
unlikely that a single therapy will effectively manage all or 
even most patients with the condition[42]. In addition to 
general measures such as reassurance and avoiding obvious 
precipitants, the most commonly available options are: 
(1) Eradication of  H pylori infection; (2) Acid reducing 
therapy; (3) Gastrokinetic agents
Eradication of helicobacter pylori infection
In patients where abdominal pain is the most bothersome 
symptom especially if  ulcer-like in character, current 
practice frequently involves eradication of  H pylori 
par t icularly in regions where H pylor i infection is 
endemic[42]. This has the advantage of  treating patients 
where the diagnosis of  peptic ulcer has been missed as 
well as reducing the risk of  subsequent malignancy. These 
patients may well be cured, although it must be recognised 
that the overall direct therapeutic gain from this approach 
in dyspeptic patients in general is small[43].
Acid-reducing therapy
Although ulcer-like symptoms would be expected to 
benefit from acid suppression with simple antacids, H2 
receptor antagonists or more recently proton pump 
inhibitors, the therapeutic benefit is small[42,44]. Some of  
this may derive from successful management of  hidden 
GORD and peptic ulcer disease. 
Gastrokinetic drugs
Data indicating that patients who have predominant 
pain are associated with hypersensitivity to gastric 
distension suggests that targeting modulation of  gastric 
accommodation (such as 5HT1 antagonists) may have a 
role in the future management[2] although such approaches 
are at present in limited use. In patients with dysmotility-
like symptoms prokinetic therapy is a rational approach 
especially if  supported by objective evidence of  delayed 
gastric emptying or a positive response to a satiety drinking 
test. Cisapride, a substituted benzamide with activity as a 
5HT4 agonist, was arguably the most effective prokinetic 
agent although the evidence for an effect on symptoms 
is controversial[42]. The drug has been withdrawn in 
many countries due to rare but life-threatening cardiac 
toxicity. Another 5-HT4 agonist with prokinetic activity, 
mosapride[45], has not been widely released. Newer 
agents such as tegaserod[46] and itopride[47] are currently 
undergoing evaluation. In patients with H pylori gastritis 
there is the theoretical possibility that gastritis-induced 
hypersensitivity may be ameliorated by treating the 
infection[35].
In conclusion, the sub-classification of  functional 
dyspepsia is currently in transition. The early expec-
tation that particular subtypes based on dominant 
symptom clusters would be associated with specific 
pathophysiologic disturbances has not been realised, 
although these descriptive terms remain entrenched in 
clinical practice. More recent data support a division 
into pathophysiologically-based patient groupings. In 
particular there appears to be an association between slow 
gastric emptying and dysmotility-like symptoms whilst 
hypersensitivity to gastric distension is more common 
in patients with post prandial pain. Eradication of  H 
pylori gastritis has limited direct therapeutic gain. Patients 
with predominantly reflux symptoms need exclusion of  
GORD. Until further data are available it seems rationale 
to base initial therapy on the suspected pathophysiological 
abnormalities rather than symptoms, although well 
evaluated therapeutic options are limited. Further research 
is required to clarify the relationship between symptoms 
and motor and sensory dysfunction to provide an 
evidence-based management strategy. 
REFERENCES
1 Talley N, Colin-Jones D, Koch KL. Functional dyspepsia. A 
classifi cation with guidelines for diagnosis and management. 
Gastroenterol Int 1991; 4: 145-160
2 Tack J , Bisschops R, Sarnelli G. Pathophysiology and 
treatment of functional dyspepsia. Gastroenterology 2004; 127: 
1239-1255
3 Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, 
Thompson WG, Whitehead WE, Janssens J, Funch-Jensen 
P, Corazziari E. U.S. householder survey of functional 
gastrointestinal disorders. Prevalence, sociodemography, and 
health impact. Dig Dis Sci 1993; 38: 1569-1580
4 Meineche-Schmidt V, Jorgensen T. Investigation and therapy 
in patients with different types of dyspepsia: a 3 year follow-
up study from general practice. Fam Pract 2000; 17: 514-521
5 El-Serag HB, Talley NJ. Systemic review: the prevalence and 
clinical course of functional dyspepsia. Aliment Pharmacol Ther 
2004; 19: 643-654
6 Talley NJ, Vakil NB, Moayyedi P. American gastroenterological 
association technical review on the evaluation of dyspepsia. 
Gastroenterology 2005; 129: 1756-1780
7 Talley N, Stanghellini V, Heading RC, Koch KL, Malagelada 
JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 
45 Suppl 2: II37- II42
8 Talley N, Stanghellini V, Heading R, Koch K, Malagelada JR, 
Tytgat GN. Functional gastroduodenal disorders. In: Dross-
man DA, ed. Rome II: the functional gastrointestinal disorders. 
McLean, VA: Degnon, 2000: 299-350
9 Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ, 3rd. 
Dyspepsia and dyspepsia subgroups: a population-based 
study. Gastroenterology 1992; 102: 1259-1268
10 Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, 
Daniels S, Escobedo S, Chakraborty B, Sinclair P, Van Zanten 
SJ. The prevalence of clinically signifi cant endoscopic fi ndings 
in primary care patients with uninvestigated dyspepsia: the 
Canadian Adult Dyspepsia Empiric Treatment - Prompt 
Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003; 
17: 1481-1491
11 Eslick GD, Howell SC, Hammer J, Talley NJ. Empirically 
derived symptom sub-groups correspond poorly with 
diagnostic criteria for functional dyspepsia and irritable bowel 
syndrome. A factor and cluster analysis of a patient sample. 
Aliment Pharmacol Ther 2004; 19: 133-140
12 Grainger SL, Klass HJ, Rake MO, Williams JG. Prevalence 
of dyspepsia: the epidemiology of overlapping symptoms. 
Postgrad Med J 1994; 70: 154-161
13 Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel 
2670         ISSN 1007-9327      CN 14-1219/ R     World J Gastroenterol          May 7, 2006      Volume 12    Number 17
www.wjgnet.com
syndrome and dyspepsia in the general population: overlap 
and lack of stability over time. Gastroenterology 1995; 109: 
671-680
14 Bytzer P, Hansen JM, Havelund T, Malchow-Moller A, Schaf-
falitzky de Muckadell OB. Predicting endoscopic diagnosis 
in the dyspeptic patient: the value of clinical judgement. Eur J 
Gastroenterol Hepatol 1996; 8: 359-363
15 Talley NJ , Phung N, Kalantar JS . ABC of the upper 
gastrointestingal tract: Indigestion: When is it functional? BMJ 
2001; 323: 1294-1297
16 Talley NJ, Boyce P, Jones M. Identifi cation of distinct upper 
and lower gastrointestinal symptom groupings in an urban 
population. Gut 1998; 42: 690-695
17 Holtmann G, Stanghellini V, Talley NJ. Nomenclature of 
dyspepsia, dyspepsia subgroups and functional dyspepsia: 
clarifying the concepts. Baillieres Clin Gastroenterol 1998; 12: 
417-433
18 Collen MJ, Abdulian JD, Chen YK. Gastroesophageal refl ux 
disease in the elderly: more severe disease that requires 
aggressive therapy. Am J Gastroenterol 1995; 90: 1053-1057
19 Camilleri M, Talley NJ. Pathophysiology as a basis for 
understanding symptom complexes and therapeutic targets. 
Neurogastroenterol Motil 2004; 16: 135-142
20 Narducci F, Bassotti G, Granata MT, Gaburri M, Farroni F, 
Palumbo R, Morelli A. Functional dyspepsia and chronic 
idiopathic gastric stasis. Role of endogenous opiates. Arch 
Intern Med 1986; 146: 716-720
21 Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout 
AJ, Hoes AW. Disturbed solid-phase gastric emptying in 
functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43: 
2028-2033
22 Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens 
J. Symptoms associated with hypersensitivity to gastric 
distention in functional dyspepsia. Gastroenterology 2001; 
121:526-535
23 Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role 
of impaired gastric accommodation to a meal in functional 
dyspepsia. Gastroenterology 1998; 115: 1346-1352
24 Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric 
and autonomic responses to stress in functional dyspepsia. 
Dig Dis Sci 1986; 31: 1169-1177
25 Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J 
Gastroenterol Suppl 1996; 220: 19-22
26 Talley NJ , Fet t SL, Zinsmeister AR, Melton LJ 3rd. 
Gastrointestinal tract symptoms and self-reported abuse: a 
population-based study. Gastroenterology 1994; 107: 1040-1049
27 Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, 
Coderch J, Perona M. Dyspepsia and irritable bowel syndrome 
after a Salmonella gastroenteritis outbreak: one-year follow-up 
cohort study. Gastroenterology 2005; 129: 98-104
28 Stanghellini V, Tosetti C, Paternic inverted question marko 
A, Barbara G, Morselli-Labate AM, Monetti N, Marengo M, 
Corinaldesi R. Risk indicators of delayed gastric emptying of 
solids in patients with functional dyspepsia. Gastroenterology 
1996; 110: 1036-1042
29 Perri F, Clemente R, Festa V, Annese V, Quitadamo M, 
Rutgeerts P, Andriulli A. Patterns of symptoms in functional 
dyspepsia: role of Helicobacter pylori infection and delayed 
gastric emptying. Am J Gastroenterol 1998; 93: 2082-2088
30 Tack J, Caenepeel P, Piessevaux H, Cuomo R, Janssens J. 
Assessment of meal induced gastric accommodation by 
a satiety drinking test in health and in severe functional 
dyspepsia. Gut 2003; 52: 1271-1277
31 Kuiken SD, Samsom M, Camilleri M, Mullan BP, Burton 
DD, Kost LJ, Hardyman TJ, Brinkmann BH, O’Connor MK. 
Development of a test to measure gastric accommodation in 
humans. Am J Physiol 1999; 277: G1217- G1221
32 Gilja OH , Hausken T, Odegaard S, Berstad A. Three-
dimensional ultrasonography of the gastric antrum in patients 
with functional dyspepsia. Scand J Gastroenterol 1996; 31: 
847-855
33 Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired 
accommodation of proximal stomach to a meal in functional 
dyspepsia. Dig Dis Sci 1996; 41: 689-696
34 Armstrong D. Helicobacter pylori infection and dyspepsia. 
Scand J Gastroenterol Suppl 1996; 215: 38-47
35 Talley NJ, Hunt RH. What role does Helicobacter pylori play 
in dyspepsia and nonulcer dyspepsia? Arguments for and 
against H. pylori being associated with dyspeptic symptoms. 
Gastroenterology 1997; 113: S67-S77
36 Sarnelli G, Cuomo R, Janssens J, Tack J. Symptom patterns 
and pathophysiological mechanisms in dyspeptic patients 
with and without Helicobacter pylori. Dig Dis Sci 2003; 48: 
2229-2236
37 Schlemper RJ, van der Werf SD, Vandenbroucke JP, Biemond 
I, Lamers CB. Nonulcer dyspepsia in a Dutch working 
population and Helicobacter pylori . Ulcer history as an 
explanation of an apparent association. Arch Intern Med 1995; 
155: 82-87
38 Feinle C, Meier O, Otto B, D’Amato M, Fried M. Role of 
duodenal lipid and cholecystokinin A receptors in the 
pathophysiology of functional dyspepsia. Gut 2001; 48: 347-355
39 Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout 
AJ. Abnormal clearance of exogenous acid and increased acid 
sensitivity of the proximal duodenum in dyspeptic patients. 
Gastroenterology 1999; 116: 515-520
40 Accarino AM, Azpiroz F, Malagelada JR. Attention and 
distraction: effects on gut perception. Gastroenterology 1997; 
113: 415-422
41 Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, 
Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 
CC genotype is associated with unexplained (functional) 
dyspepsia. Gastroenterology 2004; 126: 971-979
42 Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr 
Treat Options Gastroenterol 2005; 8: 325-336
43 Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, 
Oakes R, Wilson S, Roalfe A, Bennett C, Forman D. Eradication 
of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database 
Syst Rev 2005: CD002096
44 Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The 
efficacy of proton pump inhibitors in nonulcer dyspepsia: a 
systematic review and economic analysis. Gastroenterology 
2004; 127: 1329-1337
45 Otaka M , Jin M, Odashima M, Matsuhashi T, Wada I, 
Horikawa Y, Komatsu K, Ohba R, Oyake J, Hatakeyama N, 
Watanabe S. New strategy of therapy for functional dyspepsia 
using famotidine, mosapride and amitriptyline. Aliment 
Pharmacol Ther 2005; 21 Suppl 2: 42-46
46 Thumshim M, Fruehauf H, Stutz B, Tougas G, Salter J, Fried 
M. Effects of tegaserod on gastric motor and sensory function 
inpatients with functional dyspepsia. Gastroenterology 2005; 
128: A-469
47 Holtmann G, Schnittler J, Boos G, Matiba B, Tallet N. A 
randomised double;blind placebo-controlled dose finding 
study of Itopride for treatment of patients with functional 
dyspepsia. Gastroenterology 2004; 126: A-100
S- Editor  Pan BR   E- Editor  Bai SH
Baker G et al . Dyspepsia sub-types                                                                 2671
www.wjgnet.com
